Cosmos Holdings (COSM) AI Stock Analysis

• Market Cap: $12.78M
• Dividend Yield: N/A
• Average Volume (3M): 1.18M
• Price to Earnings (P/E): ―
• Beta (1Y): 2.29
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 149
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): -0.53
• Shares Outstanding: 37,432,520
• 10 Day Avg. Volume: 1,246,475
• 30 Day Avg. Volume: 1,183,471
• PEG Ratio: 0.02
• Price to Book (P/B): 0.52
• Price to Sales (P/S): 0.24
• P/FCF Ratio: -1.57
• Enterprise Value/Market Cap: 2.27
• Enterprise Value/Revenue: 0.48
• Enterprise Value/Gross Profit: 4.25
• Enterprise Value/Ebitda: -1.94
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 40 Underperform
• Price Target: $0.48 ▼(-7.69% Downside)
• Action: Reiterated Date: 01/14/26
• Date: Action: Reiterated 01/14/26

The score is driven primarily by weak financial performance (losses and negative cash flow) and bearish technicals (below key moving averages with negative MACD). Valuation is constrained by unprofitability (negative P/E), and the Nasdaq non-compliance notice adds additional downside risk.

Positive Factors

Robust supply chain & distribution network

A global, well-established distribution network and supply chain provide durable competitive advantage by enabling broad market coverage, lower logistics disruption risk, and scalable wholesale/retail distribution. This supports steady revenue access across channels over months.

Negative Factors

Persistent unprofitability & weak margins

Negative net and EBIT margins show the company is not yet converting sales into sustainable profits. Over time this pressures retained earnings, limits reinvestment capacity, and forces reliance on external financing or corrective restructuring to achieve durable profitability.

Cosmos Holdings Business Overview & Revenue Model

Company Description

Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and o...

Read more

Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and o...

How the Company Makes Money

Cosmos Holdings generates revenue through multiple streams, including the wholesale distribution of pharmaceuticals, which involves sourcing products from manufacturers and selling them to pharmacies, hospitals, and clinics. The company also profi...

Read more

Cosmos Holdings generates revenue through multiple streams, including the wholesale distribution of pharmaceuticals, which involves sourcing products from manufacturers and selling them to pharmacies, hospitals, and clinics. The company also profi...

Cosmos Holdings Financial Statement Overview

Breakdown	TTM	Mar 2025	Jun 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	59.79M	54.43M	53.38M	50.35M	56.24M	55.41M
Gross Profit	6.82M	4.31M	4.35M	5.96M	8.33M	8.06M
EBITDA	-14.92M	-13.92M	-17.06M	-8.90M	-3.82M	4.39M
Net Income	-18.54M	-16.18M	-18.54M	-13.83M	-7.96M	820.79K
Balance Sheet
Total Assets	69.49M	54.31M	66.01M	68.04M	49.43M	43.84M
Cash, Cash Equivalents and Short-Term Investments	922.62K	336.25K	3.85M	20.76M	297.95K	851.19K
Total Debt	21.07M	11.82M	12.42M	12.03M	27.12M	32.04M
Total Liabilities	46.36M	29.78M	29.97M	28.38M	45.05M	48.01M
Stockholders Equity	23.13M	24.53M	36.04M	39.66M	4.38M	-4.16M
Cash Flow
Free Cash Flow	-10.27M	-8.14M	-24.80M	-15.25M	-7.99M	-11.62M
Operating Cash Flow	-9.20M	-7.72M	-15.64M	-14.87M	-7.10M	-11.50M
Investing Cash Flow	-1.95M	-798.27K	-13.76M	-21.50K	-826.82K	-117.74K
Financing Cash Flow	12.49M	5.05M	12.69M	35.05M	7.27M	12.46M

Cosmos Holdings Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.52
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For COSM, the sentiment is Negative. The current price of 0.52 is above the 20-day moving average (MA) of 0.36, above the 50-day MA of 0.41, and below the 200-day MA of 0.64, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 40.88 is Neutral, neither overbought nor oversold. The STOCH value of 51.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for COSM.

Cosmos Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TXMD	52 Neutral	$26.51M	20.56	0.27%	―	75.19%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SCYX	50 Neutral	$39.34M	-3.67	-19.05%	―	-65.77%	38.61%
AYTU	45 Neutral	$29.14M	-0.62	-107.16%	―	-15.61%	-68.96%
PRPH	42 Neutral	$775.22K	-0.70	-404.42%	―	―	―
RMTI	42 Neutral	$40.98M	-6.17	-16.77%	―	-23.60%	-179.33%
COSM	40 Underperform	$12.78M	-1.59	-63.82%	―	―	―

Cosmos Holdings Corporate Events